Health Condition 1: J80- Acute respiratory distress syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subject will be included only when diagnosed with COPD with Acute Respiratory Failure by the Intensivist or Respiratory Medicine Specialist, by the criteria of partial pressure of arterial oxygen (PaO2) less than 60 mmHg from ABG analysis report or a pulse oximetry reading (SpO2) less than 90%. (Naughton, 2020) 2. Subject will be included when admitted to the ICU and will be on non-invasive or invasive mechanical ventilation within 24 hours with standard PEEP of 5 2 cm H2O. with CPAP mode. (Grieco, 2021) 3. Independent in functional activities before admission to the hospital.
Exclusion criteria
Exclusion criteria: 1. Subject will be excluded if not diagnosed with COPD with ARF. 2. Subject will be excluded if they have a history of undergoing any surgery, like thoracic, cardiac, abdominal, or fractures. 3. Subject will be excluded if they have any condition that restricts mobility. 4. Subject will be excluded if they have ulcers or open wounds. 5. Subject will be excluded if they have been medically diagnosed with Cancer or metastasis or history of Chemotherapy or radiotherapy within the previous 6 months. 6. Subject will be excluded if they have already been medically diagnosed with neurological deficits or neuromuscular disease 7. Subject will be excluded if they have invasive femoral arterial lines or are on immunosuppression therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PaO2 - ABG InvestigationTimepoint: Base Line & on the 5th day | — |
Secondary
| Measure | Time frame |
|---|---|
| SpO2 Pulse OximeterTimepoint: Base Line & on the 5th day;Fatigue - Fatigue Assessment Scale (FAS)Timepoint: Base Line & on the 5th day;Perme Intensive Care Unit Mobility ScoreTimepoint: Base Line & on the 5th day;Respiratory Distress Observation Scale (RDOS)Timepoint: Base Line & on the 5th day | — |
Countries
India
Contacts
Ravi Nair Physiotherapy College, Wardha